Ketamine and n-butyl-p-aminobezoate in PLO
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 25, 2000
Grant Date -
N/A
app pub date -
Jul 8, 1999
filing date -
Jul 8, 1999
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to a novel ointment combining Ketamine and n-butyl-p-aminobenzoate (BAB) that is self-administered topically by a subject to alleviate Neuropathic pain, Sympathetic Mediated pain, TMJ pain, SIJ pain and Osteoarthritic pain said subject is experiencing. The present invention is an improvement over the Ketamine only based ointment disclosed in U.S. Pat. No. 5,817,699.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully